Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 EUR | -0.19% | -10.02% | +20.93% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 12/09/10 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Michael Smith
CMP | Compliance Officer | - | - |
Brent Gardner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jebediah Ledell
COO | Chief Operating Officer | 49 | 30/11/21 |
Stefanie Solomon
CMP | Compliance Officer | - | - |
Anisha Wharton
LAW | General Counsel | - | 31/12/20 |
Danielle Holland
LAW | General Counsel | - | - |
David Crist
SAM | Sales & Marketing | - | 18/10/20 |
Corporate Officer/Principal | - | 30/11/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 12/09/10 | |
Jaywin Lee
BRD | Director/Board Member | - | 18/01/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,763,127 | 34,693,418 ( 99.80 %) | 0 | 99.80 % |
Company contact information
AVEO Pharmaceuticals, Inc.
1 Marina Park Drive 12th floor
02210, Boston
+857 400 0101
http://www.aveooncology.comSector
1st Jan change | Capi. | |
---|---|---|
-0.36% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- AVEO Stock
- VPA Stock
- Company AVEO Pharmaceuticals, Inc.